IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Recruiting now · Phase 1
Conditions studied: Nontuberculous Mycobacterium Infection
In brief
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)
Key facts
- Study ID
- NCT04294043
- Run by
- Chris Goss
- People needed
- 40
- Starts
- 2021-06-17
- Expected to finish
- 2027-03-31
- Last updated by the study team
- 2025-10-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
- National Jewish Health — Denver, Colorado, United States (enrolling)
- Johns Hopkins University — Baltimore, Maryland, United States (enrolling)
- The Minnesota Cystic Fibrosis Center — Minneapolis, Minnesota, United States (enrolling)
- Nationwide Children's Hospital — Columbus, Ohio, United States (enrolling)
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States (enrolling)
- Medical University of South Carolina — Charleston, South Carolina, United States (enrolling)
- University of Texas Southwestern — Dallas, Texas, United States (enrolling)
- University of Vermont Medical Center — Burlington, Vermont, United States (enrolling)
- University of Washington Medical Center — Seattle, Washington, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.